Уважаемые пользователи!
Мы рады представить вам новую версию сайта с улучшенным интерфейсом и новыми возможностями.
Приглашаем вас ознакомиться и поделиться обратной связью. Спасибо, что вы с нами!
Попробовать!

Long-Term Functional and Clinical Follow-Up of Heart Failure Patients with Recovered Left Ventricular Ejection Fraction After Beta-Blocker Therapy

24.02.20141841
Some patients with left ventricular systolic dysfunction (LVSD) have a dramatic improvement in left ventricular ejection fraction (LVEF) after beta-blockade.

Calcium channel blockers improve exercise capacity and reduce N-terminal Pro-B-type natriuretic peptide levels compared with beta-blockers in patients with permanent atrial fibrillation

21.02.20141700
Rate control of atrial fibrillation (AF) has become a main treatment modality, but we need more knowledge regarding the different drugs used for this purpose.

Risk of drug-induced liver injury with the new oral anticoagulants: systematic review and meta-analysis

20.02.20141759
Objective In recent years, safety alerts have been made warning of the risk of serious drug-induced liver injury (DILI) caused by cardiovascular drugs.

A new European Heart Journal International Editorial Board Member

19.02.20142656
Professor Evgeny Shlyakhto, MD, PhD, FESC, FACC, President of the Russian Society of Cardiology joined the European Heart Journal (EHJ) as an editorial board member in January 2014.

Scientific meeting with participation of Jean-Charles Fruchart took place in Almazov Centre

19.02.20142512
On February 7, 2014 International scientific conference “Translational and personalized medicine.

Duration of dual antiplatelet therapy following percutaneous coronary intervention on re-hospitalization for acute coronary syndrome

19.02.20141633
The optimal duration of dual antiplatelet therapy after percutaneous coronary intervention (PCI) remains uncertain.

Anna Kontsevaya tells about the educational forum of young cardiologists

18.02.20143050
This is the second forum of young cardiologists which is organized in Russia. It is radically different from the first forum which was in Samara in 2012 due to form and content.
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.